期刊
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
卷 71, 期 7, 页码 773-799出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00228-015-1862-7
关键词
Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Immunomodulators; Biologics
资金
- MSD
Background The following review is a compilation of the recent advances and knowledge on the behaviour of the most frequently used compounds to treat inflammatory bowel disease in an organism. Results It considers clinical aspects of each entity and the pharmacokinetic/pharmacodynamic relationship supported by the use of plasma monitoring, tissue concentrations, and certain aspects derived from pharmacogenetics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据